|
Volume
18 Number 1
31 January 2016
|
|
Home
>
Publications
>
Current
Neuro-Oncology >
Volume
18, Year 2016 >
Number 1, 31 January
|
|
|
|
|
|
Dodgshun
AJ, Maixner WJ, Hansford JR, Sullivan MJ.
Low
rates of recurrence and slow progression of pediatric pilocytic
astrocytoma after gross-total resection: justification for
reducing surveillance imaging.
J
Neurosurg Pediatr.
2016 Jan 1, 2016;17(5):569-72→.
doi: 10.3171/2015.9.PEDS15449→.
PMID: 26722760→.
Observational
study. ˍ
|
|
|
|
Rønning
PA, Helseth E, Meling TR, Johannesen TB.
The
effect of pregnancy on survival in a low-grade glioma cohort.
J
Neurosurg.
2016 Jan 1, 2016;125(2):393-400→.
doi: 10.3171/2015.6.JNS15985→.
PMID: 26722849→.
Observational
study. ˍ
|
|
|
|
Yuan
Y, Shi Q, Li M, Nagamuthu C, Andres E, Davis FG.
Canadian
brain cancer survival rates by tumour type and region:
1992-2008.
Can
J Public Health. 2016 Jan 1, 2016;107(1):e37-42→.
doi: 10.17269/cjph.107.5209→.
PMID: 27348108→.
Observational study. ˍ
|
|
|
|
Takeuchi
H, Kitai R, Hosoda T, Yamada S, Hashimoto N, Kikuta K, Shimizu Y,
Kimura H.
Clinicopathologic
features of small cell glioblastomas.
J
Neurooncol.
2016 Jan 2, 2016;127(2):337-44→.
doi: 10.1007/s11060-015-2038-0→.
PMID: 26725094→.
Observational
study. ˍ
|
|
|
|
Zhang
G, Huang S, Zhang J, Wu Z, Lin S, Wang Y.
Clinical
outcome of gliosarcoma compared with glioblastoma multiforme: a
clinical study in Chinese patients.
J
Neurooncol.
2016 Jan 2, 2016;127(2):355-62→.
doi: 10.1007/s11060-015-2046-0→.
PMID: 26725096→.
Observational
study. ˍ
|
|
|
|
Egan
G, Cervone KA, Philips PC, Belasco JB, Finlay JL, Gardner SL.
Phase
I study of temozolomide in combination with thiotepa and
carboplatin with autologous hematopoietic cell rescue in patients
with malignant brain tumors with minimal residual disease.
Bone
Marrow Transplant.
2016 Jan 4, 2016;51(4):542-5→.
doi: 10.1038/bmt.2015.313→.
PMID: 26726947→.
Interventional
study. ˍ
|
|
|
|
Galvis
L, Gonzalez D, Bonilla C.
Relapsed
High-Risk Medulloblastoma: Stable Disease after Two Years of
Treatment with Somatostatin Analog - Case Report.
Cureus.
2016 Jan 4;8(1):e446→.
doi: 10.7759/cureus.446→.
PMID: 26918214→
Case
report. ˍ
|
|
|
|
Strowd
RE, Abuali I, Ye X, Lu Y, Grossman SA.
The
role of temozolomide in the management of patients with newly
diagnosed anaplastic astrocytoma: a comparison of survival in the
era prior to and following the availability of temozolomide.
J
Neurooncol.
2016 Jan 4, 2016;127(1):165-71→.
doi: 10.1007/s11060-015-2028-2→.
PMID: 26729269→.
Observational
study.
ˍ
|
|
|
|
Doron
O, Zauberman J, Feldman Z.
A
medulloblastoma showing an unusually long doubling time:
reflection of its singular nature.
Childs
Nerv Syst.
2016 Jan 6, 2016;32(6):1153-6→.
doi: 10.1007/s00381-015-2997-7→.
PMID: 26738874→.
Case
report. ˍ
|
|
|
|
Broniscer
A, Chamdine O, Hwang S, Lin T, Pounds S, Onar-Thomas A, Shurtleff
S, Allen S, Gajjar A, Northcott P, Orr BA.
Gliomatosis
cerebri in children shares molecular characteristics with other
pediatric gliomas.
Acta
Neuropathol.
2016 Jan 7, 2016;131(2):299-307→.
doi: 10.1007/s00401-015-1532-y→.
PMID: 26744350→.
Observational
study. _
|
|
|
|
Herrlinger
U, Jones DT, Glas M, Hattingen E, Gramatzki D, Stuplich M,
Felsberg J, Bähr O, Gielen GH, Simon M, Wiewrodt D, Schabet
M, Hovestadt V, Capper D, Steinbach JP, von Deimling A, Lichter P,
Pfister SM, Weller M, Reifenberger G.
Erratum
to: Gliomatosis cerebri: no evidence for a separate brain tumor
entity.
Acta
Neuropathol. 2016 Jan 7, 2016;131(2):321-2→.
doi: 10.1007/s00401-015-1523-z→.
PMID: 26744347→.
Correction.
ˍ
Refers
to: Herrlinger
U, et al., Gliomatosis cerebri: no evidence for a separate brain
tumor entity.
Acta Neuropathol. 2015 Oct 22,
2016;131(2):309-319→.
doi: 10.1007/s00401-015-1495-z→.
PMID:
26493382→.
Laboratory
investigation. ˍ
|
|
|
|
Ansstas
G, Tran DD.
Treatment
with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in
Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A
Case Series.
Case
Rep Neurol. 2016 Jan 8;8(1):1-9→.
doi: 10.1159/000442196→.
PMID: 26889149→.
Case
report. ˍ
|
|
|
|
Quick-Weller
J, Lescher S, Forster MT, Konczalla J, Seifert V, Senft C.
Combination
of 5-ALA and iMRI in re-resection of recurrent glioblastoma.
Br
J Neurosurg.
2016 Jan 8, 2016;30(3):313-7→.
doi: 10.3109/02688697.2015.1119242→.
PMID: 26743016→.
Case
report. ˍ
|
|
|
|
Taha
MS, Abdalhamid BA, El-Badawy SA, Sorour YM, Almsned FM, Al-Abbadi
MA.
Expression
of cytomegalovirus in glioblastoma multiforme: Myth or reality?
Br
J Neurosurg.
2016 Jan 8, 2016;30(3):307-12→.
doi: 10.3109/02688697.2015.1119241→.
PMID: 26742571→.
Observational
study. ˍ
|
|
|
|
Louvel
G, Metellus P, Noel G, Peeters S, Guyotat J, Duntze J, Le Reste
PJ, Dam Hieu P, Faillot T, Litre F, Desse N, Petit A, Emery E,
Voirin J, Peltier J, Caire F, Vignes JR, Barat JL, Langlois O,
Menei P, Dumont SN, Zanello M, Dezamis E, Dhermain F, Pallud J;
Club de Neuro-Oncologie of Société Française
deNeurochirurgie.
Delaying
standard combined chemoradiotherapy after surgical resection does
not impact survival in newly diagnosed glioblastoma
patients.
Radiother
Oncol.
2016 Jan 11, 2016;118(1):9-15→.
doi: 10.1016/j.radonc.2016.01.001→.
PMID: 26791930→.
Observational
study. ˍ
|
|
|
|
Bao
Y, Qiu B, Qi S, Pan J, Lu Y, Peng J.
Influence
of previous treatments on repeat surgery for recurrent
craniopharyngiomas in children.
Childs
Nerv Syst.
2016 Jan 12, 2016;32(3):485-91→.
doi: 10.1007/s00381-015-3003-0→.
PMID: 26758881→.
Observational
study. ˍ
|
|
|
|
Erdem-Eraslan
L, van den Bent MJ, Hoogstrate Y, Naz-Khan H, Stubbs A, van der
Spek P, Böttcher R, Gao Y, de Wit M, Taal W, Oosterkamp HM,
Walenkamp A, Beerepoot LV, Hanse MC, Buter J, Honkoop AH, van der
Holt B, Vernhout RM, Sillevis Smitt PA, Kros JM, French PJ.
Identification
of Patients with Recurrent Glioblastoma Who May Benefit from
Combined Bevacizumab and CCNU Therapy: A Report from the BELOB
Trial.
Cancer
Res.
2016 Jan 13, 2016;76(3):525-34→.
doi: 10.1158/0008-5472.CAN-15-0776→.
PMID: 26762204→.
Interventional
study. ˍ
|
|
|
|
Hinrichs
BH, Newman S, Appin CL, Dunn W, Cooper L, Pauly R, Kowalski J,
Rossi MR, Brat DJ.
Farewell
to GBM-O: Genomic and transcriptomic profiling of glioblastoma
with oligodendroglioma component reveals distinct molecular
subgroups.
Acta
Neuropathol Commun.
2016 Jan 13, 2016;4:4→.
doi: 10.1186/s40478-015-0270-7→.
PMID: 26757882→.
Laboratory
investigation. ˍ
|
|
|
|
Morrissy
AS, Garzia L, Shih DJ, Zuyderduyn S, Huang X, Skowron P, Remke M,
Cavalli FM, Ramaswamy V, Lindsay PE, Jelveh S, Donovan LK, Wang X,
Luu B, Zayne K, Li Y, Mayoh C, Thiessen N, Mercier E, Mungall KL,
Ma Y, Tse K, Zeng T, Shumansky K, Roth AJ, Shah S, Farooq H,
Kijima N, Holgado BL, Lee JJ, Matan-Lithwick S, Liu J, Mack SC,
Manno A, Michealraj KA, Nor C, Peacock J, Qin L, Reimand J,
Rolider A, Thompson YY, Wu X, Pugh T, Ally A, Bilenky M,
Butterfield YS, Carlsen R, Cheng Y, Chuah E, Corbett RD, Dhalla N,
He A, Lee D, Li HI, Long W, Mayo M, Plettner P, Qian JQ, Schein
JE, Tam A, Wong T, Birol I, Zhao Y, Faria CC, Pimentel J, Nunes S,
Shalaby T, Grotzer M, Pollack IF, Hamilton RL, Li XN, Bendel AE,
Fults DW, Walter AW, Kumabe T, Tominaga T, Collins VP, Cho YJ,
Hoffman C, Lyden D, Wisoff JH, Garvin JH Jr, Stearns DS, Massimi
L, Schüller U, Sterba J, Zitterbart K, Puget S, Ayrault O,
Dunn SE, Tirapelli DP, Carlotti CG, Wheeler H, Hallahan AR, Ingram
W, MacDonald TJ, Olson JJ, Van Meir EG, Lee JY, Wang KC, Kim SK,
Cho BK, Pietsch T, Fleischhack G, Tippelt S, Ra YS, Bailey S,
Lindsey JC, Clifford SC, Eberhart CG, Cooper MK, Packer RJ,
Massimino M, Garre ML, Bartels U, Tabori U, Hawkins CE, Dirks P,
Bouffet E, Rutka JT, Wechsler-Reya RJ, Weiss WA, Collier LS, Dupuy
AJ, Korshunov A, Jones DT, Kool M, Northcott PA, Pfister SM,
Largaespada DA, Mungall AJ, Moore RA, Jabado N, Bader GD, Jones
SJ, Malkin D, Marra MA, Taylor MD.
Divergent
clonal selection dominates medulloblastoma at recurrence.
Nature.
2016 Jan 13, 2016;529(7586):351-7→.
doi: 10.1038/nature16478→.
PMID:
26760213→.
Laboratory investigation. ˍ
|
|
|
|
Chen
AS, Paldor I, Tsui AE, Yuen TI.
Pilomyxoid
astrocytoma in the adult cerebellum.
J
Clin Neurosci. 2016 Jan 14, 2016;27:170-3. doi:
10.1016/j.jocn.2015.11.008. Case report. Source
Similar
articles
|
|
|
|
Falsini
B, Chiaretti A, Rizzo D, Piccardi M, Ruggiero A, Manni L, Soligo
M, Dickmann A, Federici M, Salerni A, Timelli L, Guglielmi G,
Lazzareschi I, Caldarelli M, Galli-Resta L, Colosimo C, Riccardi
R.
Nerve
growth factor improves visual loss in childhood optic gliomas: a
randomized, double-blind, phase II clinical trial.
Brain.
2016 Jan 14, 2016;139(Pt 2):404-14→.
doi: 10.1093/brain/awv366→.
PMID: 26767384→.
Interventional
study. ˍ
|
|
|
|
Massimino
M, Spreafico F, Pignoli E, Gandola L.
Comment
on: The UK Experience of a Treatment Strategy for Pediatric
Metastatic Medulloblastoma Comprising Intensive Induction
Chemotherapy, Hyperfractionated Accelerated Radiotherapy, and
Response Directed High-Dose Myeloablative Chemotherapy or
Maintenance Chemotherapy (Milan Strategy).
Pediatr
Blood Cancer.
2016 Jan 14→.
2016;63(6):1123-4. doi: 10.1002/pbc.25901→.
PMID: 26766787→.
Letter
to the Editor.
_
Refers
to:
Vivekanandan
S, et al., The UK Experience of a Treatment Strategy for Pediatric
Metastatic Medulloblastoma Comprising Intensive Induction
Chemotherapy, Hyperfractionated Accelerated Radiotherapy and
Response Directed High Dose Myeloablative Chemotherapy or
Maintenance Chemotherapy (Milan Strategy).
Pediatr
Blood Cancer.
2015 Aug 14, 2015;62(12):2132-9→.
doi: 10.1002/pbc.25663→.
PMID:
26274622→.
Observational study. ˍ
Letter
to the Editor in turn commented
by:
Vivekanandan
S, et al., Reply to Comment on: The UK Experience of a Treatment
Strategy for Pediatric Metastatic Medulloblastoma Comprising
Intensive Induction Chemotherapy, Hyperfractionated Accelerated
Radiotherapy, and Response-Directed High-Dose Myeloablative
Chemotherapy or Maintenance Chemotherapy (Milan Strategy).
Pediatr
Blood Cancer. 2016 Feb 17, 2016;63(6):1125-6→.
doi: 10.1002/pbc.25946→.
PMID: 26891280→.
Letter
to the Editor. ˍ
|
|
|
|
Brehmer
S, Guthier CV, Clausen S, Schneider F, Schulte DM, Benker M,
Bludau F, Glatting G, Marx A, Schmiedek P, Hesser J, Wenz F,
Giordano FA.
Combined
stereotactic biopsy and stepping-source interstitial irradiation
of unresectable glioblastoma multiforme.
J
Neurosurg Sci.
2016 Jan 15, 2018;62(2):214-220→.
doi:
10.23736/S0390-5616.16.03547-X→.
PMID:
26771176→.
Observational
study; ˍ
|
|
|
|
Cirkel
GA, Kerklaan BM, Vanhoutte F, der Aa AV, Lorenzon G, Namour F,
Pujuguet P, Darquenne S, de Vos FY, Snijders TJ, Voest EE,
Schellens JH, Lolkema MP.
A
dose escalating phase I study of GLPG0187, a broad spectrum
integrin receptor antagonist, in adult patients with progressive
high-grade glioma and other advanced solid malignancies.
Invest
New Drugs.
2016 Jan 20, 2016;34(2):184-92→.
doi: 10.1007/s10637-015-0320-9→.
PMID: 26792581→.
Interventional
study. ˍ
|
|
|
|
Kessler
T.
Predicting
glioblastoma response to bevacizumab through marker
profiling?
Neuro
Oncol.
2016 Jan 21, 2016;18(2):149-50→.
doi: 10.1093/neuonc/nov320→.
PMID: 26803809→.
Editorial.
ˍ
Refers
to: Baumgarten
P, et al., Differential expression of vascular endothelial growth
factor A, its receptors VEGFR-1, -2, and -3 and co-receptors
neuropilin-1 and -2 does not predict bevacizumab response in human
astrocytomas.
Neuro
Oncol.
2015 Nov 30, 2016;18(2):173-83→.
doi: 10.1093/neuonc/nov288→.
PMID: 26627848→.
Observational
study. ˍ
|
|
|
|
Grossman
R, Shimony N, Hadelsberg U, Soffer D, Sitt R, Strauss N, Corn BW,
Ram Z.
Impact
of Resecting Radiation Necrosis and Pseudoprogression on Survival
of Patients with Glioblastoma.
World
Neurosurg.
2016 Jan 22, 2016;89:37-41→.
doi: 10.1016/j.wneu.2016.01.020→.
PMID: 26805684→.
Observational
study. ˍ
|
|
|
|
Saran
F, Chinot OL, Henriksson R, Mason W, Wick W, Cloughesy T, Dhar S,
Pozzi E, Garcia J, Nishikawa R.
Bevacizumab,
temozolomide, and radiotherapy for newly diagnosed glioblastoma:
comprehensive safety results during and after first-line
therapy.
Neuro
Oncol.
2016 Jan 24, 2016;18(7):991-1001→.
doi: 10.1093/neuonc/nov300→.
PMID: 26809751→.
Interventional
study. ˍ
|
|
|
|
Suchorska
B, Weller M, Tabatabai G, Senft C, Hau P, Sabel MC, Herrlinger U,
Ketter R, Schlegel U, Marosi C, Reifenberger G, Wick W, Tonn JC,
Wirsching HG.
Complete
resection of contrast-enhancing tumor volume is associated with
improved survival in recurrent glioblastoma-results from the
DIRECTOR trial.
Neuro
Oncol.
2016 Jan 27, 2015;18(4):549-56→.
doi: 10.1093/neuonc/nov326→.
PMID: 26823503→.
Interventional
study: ˍ
ˍ
|
|
|
|
Ceccarelli
M, Barthel FP, Malta TM, Sabedot TS, Salama SR, Murray BA,
Morozova O, Newton Y, Radenbaugh A, Pagnotta SM, Anjum S, Wang J,
Manyam G, Zoppoli P, Ling S, Rao AA, Grifford M, Cherniack AD,
Zhang H, Poisson L, Carlotti CG Jr, Tirapelli DP, Rao A, Mikkelsen
T, Lau CC, Yung WK, Rabadan R, Huse J, Brat DJ, Lehman NL,
Barnholtz-Sloan JS, Zheng S, Hess K, Rao G, Meyerson M, Beroukhim
R, Cooper L, Akbani R, Wrensch M, Haussler D, Aldape KD, Laird PW,
Gutmann DH; TCGA Research Network, Noushmehr H, Iavarone A,
Verhaak RG.
Molecular
Profiling Reveals Biologically Discrete Subsets and Pathways of
Progression in Diffuse Glioma.
Cell.
2016 Jan 28, 2016;164(3):550-63→.
doi: 10.1016/j.cell.2015.12.028→.
PMID: 26824661→.
Laboratory
investigation. ˍ
|
|
|
|
Tettamanti
G, Ljung R, Mathiesen T, Schwartzbaum J, Feychting M.
Birth
Size Characteristics and Risk of Brain Tumors in Early Adulthood:
Results from a Swedish Cohort Study.
Cancer
Epidemiol Biomarkers Prev.
2016 Jan 28, 2016;25(4):678-85→.
doi: 10.1158/1055-9965.EPI-15-1096→.
PMID: 26823476→.
Observational
study. ˍ
|
|
|
|
Okamoto
S, Nitta M, Maruyama T, Sawada T, Komori T, Okada Y, Muragaki Y.
Bevacizumab
changes vascular structure and modulates the expression of
angiogenic factors in recurrent malignant gliomas.
Brain
Tumor Pathol.
2016 Jan 29, 2016;33(2):129-36→.
doi: 10.1007/s10014-016-0248-6→.
PMID: 26826105→.
Case
report. ˍ
|
|
|
|
Shi
W, Palmer JD, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim
L, Bar-Ad V, Judy K, Farrell C, Simone N, Liu H, Dicker AP,
Lawrence YR.
Phase
I trial of panobinostat and fractionated stereotactic
re-irradiation therapy for recurrent high grade gliomas.
J
Neurooncol.
2016 Jan 29, 2016;127(3):535-9→.
doi: 10.1007/s11060-016-2059-3→.
PMID: 26821711→.
Interventional
study. ˍ
|
|
|
|
Grosshans
DR.
Proton
therapy for paediatric medulloblastoma.
Lancet
Oncol. 2016 Jan 30, 2016;17(3):258-9→.
doi: 10.1016/S1470-2045(15)00217-X→.
PMID: 26830376→.
Comment.
ˍ
Refers
to: Yock
TI, et al., Long-term toxic effects of proton radiotherapy for
paediatric medulloblastoma: a phase 2 single-arm study. Lancet
Oncol. 2016 Jan 29, 2016;17(3):287-298→.
doi: 10.1016/S1470-2045(15)00167-9→.
PMID: 26830377→.
Interventional study. ˍ
Erratum
in: Lancet
Oncol. 2020 Mar;21(3):e132→.
doi: 10.1016/S1470-2045(20)30104-2→.
PMID: 32135116→.
Correction. ˍ
|
|
|
|
Yock
TI, Yeap BY, Ebb DH, Weyman E, Eaton BR, Sherry NA, Jones RM,
MacDonald SM, Pulsifer MB, Lavally B, Abrams AN, Huang MS, Marcus
KJ, Tarbell NJ.
Long-term
toxic effects of proton radiotherapy for paediatric
medulloblastoma: a phase 2 single-arm study.
Lancet
Oncol. 2016 Jan 29, 2016;17(3):287-298→.
doi: 10.1016/S1470-2045(15)00167-9→.
PMID: 26830377→.
Interventional study. ˍ
Erratum
in: Lancet
Oncol. 2020 Mar;21(3):e132→.
doi: 10.1016/S1470-2045(20)30104-2→.
PMID: 32135116→.
Correction. ˍ
|
|
|
|
Mayor
S.
Proton
beam therapy is as effective as radiotherapy in childhood brain
cancer but less toxic, study shows.
BMJ.
2016 Jan 31, 2016;352:i608→.
doi: 10.1136/bmj.i608→.
PMID: 26831911→.
Comment.
ˍ
Refers
to: Yock
TI, et al., Long-term toxic effects of proton radiotherapy for
paediatric medulloblastoma: a phase 2 single-arm study. Lancet
Oncol. 2016 Jan 29, 2016;17(3):287-298→.
doi: 10.1016/S1470-2045(15)00167-9→.
PMID: 26830377→.
Interventional study. ˍ
Erratum
in: Lancet
Oncol. 2020 Mar;21(3):e132→.
doi: 10.1016/S1470-2045(20)30104-2→.
PMID: 32135116→.
Correction. ˍ
|
|
|
|
|
|
|
|
|
